China Universal Asset Management Company’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5K Sell
34,535
-3,931
-10% -$2.98K ﹤0.01% 491
2026
Q1
$26.6K Buy
38,466
+11,334
+42% +$8.36K ﹤0.01% 488
2025
Q4
$19.3K Buy
+27,132
New +$36.9K ﹤0.01% 488
2022
Q4
Sell
-387
Closed -$1K 466
2022
Q3
$1K Buy
+387
New +$1.81K ﹤0.01% 416

Other funds holding TNYA

China Universal Asset Management Company's TNYA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Tenaya Therapeutics (TNYA) stake by 10% in Q2 2026, selling an estimated $2.98K and leaving 34,535 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

China Universal Asset Management Company first reported a position in TNYA in Q3 2022 and has held it in 4 quarters since. The position peaked at $26.6K in Q1 2026. 38 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • China Universal Asset Management Company held 34,535 shares of Tenaya Therapeutics worth $25.5K as of Q2 2026.
  • China Universal Asset Management Company sold 3,931 Tenaya Therapeutics shares in Q2 2026, an estimated $2.98K.
  • Tenaya Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #491 holding.
  • China Universal Asset Management Company first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • China Universal Asset Management Company's Tenaya Therapeutics position peaked at $26.6K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.